SE408552B - Analogiforfarande for framstellning av nya pyrazoloner-(5) - Google Patents
Analogiforfarande for framstellning av nya pyrazoloner-(5)Info
- Publication number
- SE408552B SE408552B SE7405079A SE7405079A SE408552B SE 408552 B SE408552 B SE 408552B SE 7405079 A SE7405079 A SE 7405079A SE 7405079 A SE7405079 A SE 7405079A SE 408552 B SE408552 B SE 408552B
- Authority
- SE
- Sweden
- Prior art keywords
- pyrazolones
- preparation
- new
- analogical procedure
- analogical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2319279A DE2319279A1 (de) | 1973-04-17 | 1973-04-17 | Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2363138A DE2363138A1 (de) | 1973-12-19 | 1973-12-19 | Pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE408552B true SE408552B (sv) | 1979-06-18 |
Family
ID=25764995
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7405079A SE408552B (sv) | 1973-04-17 | 1974-04-16 | Analogiforfarande for framstellning av nya pyrazoloner-(5) |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US3952008A (ja) |
| JP (1) | JPS59512B2 (ja) |
| AR (2) | AR207445A1 (ja) |
| BG (2) | BG22394A3 (ja) |
| CA (1) | CA1048513A (ja) |
| CH (2) | CH603593A5 (ja) |
| DD (1) | DD113230A5 (ja) |
| DK (1) | DK136155C (ja) |
| ES (2) | ES425374A1 (ja) |
| FR (1) | FR2226171B1 (ja) |
| GB (1) | GB1424492A (ja) |
| HK (1) | HK55876A (ja) |
| HU (1) | HU168591B (ja) |
| IE (1) | IE39213B1 (ja) |
| IL (1) | IL44627A (ja) |
| LU (1) | LU69871A1 (ja) |
| NL (1) | NL7405116A (ja) |
| NO (1) | NO139439C (ja) |
| PL (1) | PL96880B1 (ja) |
| RO (2) | RO63750A (ja) |
| SE (1) | SE408552B (ja) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2319278C2 (de) * | 1973-04-17 | 1986-02-20 | Bayer Ag, 5090 Leverkusen | Pharmazeutisches Mittel |
| USRE30420E (en) * | 1973-04-17 | 1980-10-21 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| US4056533A (en) * | 1973-04-17 | 1977-11-01 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| US4000294A (en) * | 1973-04-17 | 1976-12-28 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| DE2427272C3 (de) * | 1974-06-06 | 1981-10-01 | Bayer Ag, 5090 Leverkusen | 1-(2-(β-Naphthyloxy)-äthyl)-3-methyl -pyrazolon-(5), Verfahren sowie Verwendung als Antithrombotikum |
| DE2526469A1 (de) * | 1975-06-13 | 1976-12-30 | Bayer Ag | 1-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| JPS5585571A (en) * | 1978-12-22 | 1980-06-27 | Nippon Synthetic Chem Ind Co Ltd:The | Preparation of 1,3-disubstituted-5-pyrazolone |
| JPH0730031B2 (ja) * | 1986-04-02 | 1995-04-05 | 日産化学工業株式会社 | ２―ピラゾリン―５―オン類の製造法 |
| WO2006094201A2 (en) * | 2005-03-02 | 2006-09-08 | La Jolla Pharmaceutical Company | Semicarbazide-sensitive amide oxidase inhibitors |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2376380A (en) * | 1945-05-22 | Preparation of amino pyrazolones | ||
| GB636988A (en) * | 1947-12-24 | 1950-05-10 | Gevaert Photo Producten Naamlo | Improvements in and relating to the production of colour photographic images |
| US2511231A (en) * | 1949-03-26 | 1950-06-13 | Eastman Kodak Co | 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography |
| US2600788A (en) * | 1949-06-07 | 1952-06-17 | Eastman Kodak Co | Halogen-substituted pyrazolone couplers for color photography |
| US2672417A (en) * | 1949-12-31 | 1954-03-16 | Gevaert Photo Prod Nv | Production of color photographic images |
| NL121416C (ja) * | 1961-05-31 |
-
1974
- 1974-01-01 AR AR253332A patent/AR207445A1/es active
- 1974-03-29 FR FR7411445A patent/FR2226171B1/fr not_active Expired
- 1974-04-10 HU HUBA3059A patent/HU168591B/hu unknown
- 1974-04-12 IL IL44627A patent/IL44627A/xx unknown
- 1974-04-12 BG BG026396A patent/BG22394A3/xx unknown
- 1974-04-12 BG BG029509A patent/BG22820A3/xx unknown
- 1974-04-15 DD DD177899A patent/DD113230A5/xx unknown
- 1974-04-15 US US05/461,285 patent/US3952008A/en not_active Expired - Lifetime
- 1974-04-15 JP JP49041113A patent/JPS59512B2/ja not_active Expired
- 1974-04-15 RO RO7478423A patent/RO63750A/ro unknown
- 1974-04-15 RO RO7485080A patent/RO69408A/ro unknown
- 1974-04-16 NL NL7405116A patent/NL7405116A/xx not_active Application Discontinuation
- 1974-04-16 ES ES425374A patent/ES425374A1/es not_active Expired
- 1974-04-16 CH CH524374A patent/CH603593A5/xx not_active IP Right Cessation
- 1974-04-16 DK DK207974A patent/DK136155C/da active
- 1974-04-16 SE SE7405079A patent/SE408552B/xx unknown
- 1974-04-16 LU LU69871A patent/LU69871A1/xx unknown
- 1974-04-16 PL PL74170386A patent/PL96880B1/pl unknown
- 1974-04-16 NO NO741364A patent/NO139439C/no unknown
- 1974-04-16 CH CH156777A patent/CH605799A5/xx not_active IP Right Cessation
- 1974-04-17 IE IE799/74A patent/IE39213B1/xx unknown
- 1974-04-17 GB GB1678474A patent/GB1424492A/en not_active Expired
- 1974-04-17 CA CA74197658A patent/CA1048513A/en not_active Expired
-
1975
- 1975-01-01 AR AR258463A patent/AR207242A1/es active
-
1976
- 1976-04-15 ES ES447081A patent/ES447081A1/es not_active Expired
- 1976-09-08 HK HK558/76*UA patent/HK55876A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1048513A (en) | 1979-02-13 |
| ES425374A1 (es) | 1976-09-16 |
| DK136155C (da) | 1978-01-30 |
| IE39213B1 (en) | 1978-08-30 |
| CH603593A5 (ja) | 1978-08-31 |
| NO139439C (no) | 1979-03-14 |
| AR207242A1 (es) | 1976-09-22 |
| IL44627A0 (en) | 1974-06-30 |
| FR2226171A1 (ja) | 1974-11-15 |
| HK55876A (en) | 1976-09-17 |
| BG22394A3 (bg) | 1977-02-20 |
| FR2226171B1 (ja) | 1978-07-28 |
| RO69408A (ro) | 1980-06-15 |
| JPS5012082A (ja) | 1975-02-07 |
| RO63750A (ro) | 1980-06-15 |
| DK136155B (da) | 1977-08-22 |
| JPS59512B2 (ja) | 1984-01-07 |
| ES447081A1 (es) | 1977-06-16 |
| BG22820A3 (bg) | 1977-04-20 |
| IE39213L (en) | 1974-10-17 |
| US3952008A (en) | 1976-04-20 |
| NO741364L (no) | 1974-10-18 |
| DD113230A5 (ja) | 1975-05-20 |
| LU69871A1 (ja) | 1974-11-21 |
| GB1424492A (en) | 1976-02-11 |
| NO139439B (no) | 1978-12-04 |
| NL7405116A (ja) | 1974-10-21 |
| CH605799A5 (ja) | 1978-10-13 |
| IL44627A (en) | 1978-07-31 |
| HU168591B (ja) | 1976-06-28 |
| AU6817574A (en) | 1975-10-23 |
| AR207445A1 (es) | 1976-10-08 |
| PL96880B1 (pl) | 1978-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE408179B (sv) | Analogiforfarande for framstellning av imidazo(5,1-a)-as-triaziner | |
| SE423631B (sv) | Forfarande for framstellning av oxaalhyl-dialkylxantiner | |
| SE374375B (sv) | Analogiforfarande for framstellning av nya 4-(3-karboxi-4-hydroxi-fenylazo)-bensensulfonamido-pyridiner | |
| SE7710599L (sv) | Forfarande for framstellning av bensisoxazoler | |
| SE424994B (sv) | Forfarande for framstellning av nya pseudotrisackarider | |
| SE416731B (sv) | Forfarande for framstellning av nya penicilliner | |
| SE411212B (sv) | Forfarande for framstellning av 3-halogen-cefalosporiner | |
| NO146596C (no) | Fremgangsmaate for fremstilling av 6-deoksytetracykliner | |
| SE400074B (sv) | Analogiforfarande for framstellning av nya tripeptider | |
| SE408552B (sv) | Analogiforfarande for framstellning av nya pyrazoloner-(5) | |
| SE417601B (sv) | Forfarande for framstellning av amidinokarbamider | |
| NO790627L (no) | Fremgangsmaate for fremstilling av hydroksyalkylxantiner | |
| SE418085B (sv) | Forfarande for framstellning av nya sulfamoylbensoesyraamider | |
| NO843825L (no) | Fremgangsmaate for fremstilling av 6-deoksytetracyklin | |
| SE409716B (sv) | Analogiforfarande for framstellning av 11beta-alkyl-delta4-estrener | |
| SE430065B (sv) | Forfarande for framstellning av nya 7 alfa-metoxicefalosporinderivat | |
| SE421693B (sv) | Forfarande for framstellning av n-substituerade 1-amino-3-fenoxi-propanoler-(2) | |
| SE404801B (sv) | Forfaranden for framstellning av nya tiazolderivat | |
| SE411116B (sv) | Analogiforfarande for framstellning av acetaminofenestrar av fenylsalicylsyror | |
| SE402106B (sv) | Forfarande for framstellning av nya n-(-amino)-alkylanilinderivat | |
| SE409994B (sv) | Forfarande for framstellning av amidinokarbamider | |
| SE411211B (sv) | Forfarande for framstellning av 3-halogencefalosporiner | |
| NO139125C (no) | Analogifremgangsmaate for fremstilling av cykloheksantetrolderivater | |
| SE404926B (sv) | Analogiforfarande for framstellning av 3-piperazin-isokinoliner | |
| SE415975B (sv) | Forfarande for framstellning av nya bensylpyrimidiner |